Wilbur-Ellis, San Francisco, Calif., announced that Molly Hemmeter has joined the company’s board of directors. Hemmeter most recently served as CEO, President, and Board Director of Landec Corporation, a publicly traded company in the health and wellness space, where she led a turnaround of the company’s food business and also the acquisition of Lifecore Biomedical, a manufacturer and supplier of pharmaceutical grade sodium hyaluronate.
Prior to Landec, Hemmeter served as Vice President of Global Marketing and Business Development at Ashland Chemical. She also held previous positions with software companies and a number of chemical, pharmaceutical, and consumer product companies. She holds bachelor’s and master’s degrees in chemical engineering from the University of Louisville, and an MBA from Harvard Business School.
“I’m delighted to welcome Molly Hemmeter to the Wilbur-Ellis board of directors,” said John P. Thacher, Executive Chairman of the Wilbur-Ellis board. “Molly is a visionary leader, with a focus on translating market insights into value creation. That fits perfectly with Wilbur-Ellis, which for nearly a century has been dedicated to helping our customers create value in their businesses.”